Tianjin State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China.
Institute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China.
Biomed Pharmacother. 2024 Aug;177:117112. doi: 10.1016/j.biopha.2024.117112. Epub 2024 Jul 16.
Ferroptosis is a novel form of cell demise characterized primarily by the reduction of trivalent iron to divalent iron, leading to the release of reactive oxygen species (ROS) and consequent induction of intense oxidative stress. In atherosclerosis (AS), highly accumulated lipids are modified by ROS to promote the formation of lipid peroxides, further amplifying cellular oxidative stress damage to influence all stages of atherosclerotic development. Macrophages are regarded as pivotal executors in the progression of AS and the handling of iron, thus targeting macrophage iron metabolism holds significant guiding implications for exploring potential therapeutic strategies against AS. In this comprehensive review, we elucidate the potential interplay among iron overload, inflammation, and lipid dysregulation, summarizing the potential mechanisms underlying the suppression of AS by alleviating iron overload. Furthermore, the application of Traditional Chinese Medicine (TCM) is increasingly widespread. Based on extant research and the pharmacological foundations of active compounds of TCM, we propose alternative therapeutic agents for AS in the context of iron overload, aiming to diversify the therapeutic avenues.
铁死亡是一种新型的细胞死亡形式,其特征主要为三价铁向二价铁的还原,导致活性氧(ROS)的释放,进而引起强烈的氧化应激。在动脉粥样硬化(AS)中,ROS 修饰了高度堆积的脂质,促进了脂质过氧化物的形成,进一步放大了细胞氧化应激损伤,影响了动脉粥样硬化发展的所有阶段。巨噬细胞被认为是 AS 进展和铁处理的关键执行者,因此靶向巨噬细胞铁代谢对探索针对 AS 的潜在治疗策略具有重要指导意义。在这篇全面的综述中,我们阐明了铁过载、炎症和脂质失调之间的潜在相互作用,总结了通过减轻铁过载抑制 AS 的潜在机制。此外,中药(TCM)的应用越来越广泛。基于现有研究和 TCM 活性化合物的药理学基础,我们提出了铁过载背景下用于 AS 的替代治疗药物,旨在使治疗途径多样化。